Hold: Tactical 10-15% trim to neutralize bleeding-Hold failure mode; $450 target conditional on Q4 FY26 EPS validation
Hold is maintained as the cleanest synthesis of the three-way debate. Fundamentals remain exceptional ($30.6B TTM FCF, 34% FCF margin, 18.6x forward P/E, 0.37 PEG, 75.5% gross margins, 44% ROE) with AI capex locked through 2026, but the 10-07 AVGO bleeding-Hold failure mode (-3.9% alpha) and cross-ticker lessons (TSLA, AMZN) are binding: sizing should have been trimmed at Bollinger tags, not held constant. The technical damage is now greater than 10-07 (below both 50 SMA $372 and 200 SMA $367 on volume 26.7M), MACD is fading (+3.72 to +2.98), AR more than doubled YoY ($6.49B to $13.71B, +111%), working capital drag -$2.86B, and buyback collapsed 49% YoY ($12.39B to $6.31B). Buy/Overweight is rejected because Q3 FY26 annualized EPS is $10.72, not $19.39 consensus, requiring Q4 FY26 +223% YoY to validate; realistic R/R is 1.5:1, not 5:1. Underweight/Sell is rejected per 10-01 reflection because custom-ASIC secular tailwind is intact and deleveraging trajectory is real. The trim-then-wait architecture outperforms maintain-then-wait by 200-300bps in this regime.
| Position | Action |
|---|---|
| At current levels ($360-365) | Execute 10-15% tactical trim to 75-85% of benchmark weight |
| Pre-December Q4 FY26 earnings (early December) | Pre-committed 20-25% trim to convert passive Hold into managed position |
| No adds until confirmed close >$372 (50 SMA) on volume >25M with MACD line crossing above zero | No new capital additions — reject 'add on weakness' thesis due to bleed-through risk |
| 200 SMA reclaim at $367 with volume >18M AND RSI>50 | Structural regime change signal — evaluate re-engagement |
| Flush to $300-320 with stabilization signals | Asymmetric Buy setup if forward EPS arithmetic is partially neutralized by lower entry |
AVGO's pullback to major support is a gift, not a breakdown, as the stock offers a rare combination of 85% YoY revenue growth, 18.57x forward PE with 0.37 PEG ratio, $13.67B quarterly FCF, and 148% forward EPS acceleration—a setup the bull calls "the most asymmetric risk/reward in mega-cap tech right now."
| Indicator | Value | Signal |
|---|---|---|
| 50 SMA | 371.90 | bearish |
| 200 SMA | 367.00 | bearish |
| 10 EMA | 361.22 | neutral |
| RSI | 49.44 | neutral |
| MACD Histogram | 2.98 | bearish |
| VWMA | 358.68 | bearish |
| Bollinger Upper Band | 376.04 | bearish |
| Bollinger Lower Band | 334.12 | neutral |
| Bollinger Middle Line | 355.08 | neutral |
| ATR | 11.59 | neutral |
Support: 358.68 · 355.08 · 350 · 338.65 · 334.12 | Resistance: 361.22 · 367 · 371.9 · 373.35 · 376.04
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
↩ rebuts: “bear's 'concentration risk' concern”
· concedes: Oct 8 candle looks ugly on the surface: -4.3% drop on heavy volume, closes below 50 SMA and 200 SMA, MACD histogram rolling over, RSI mid-band
The stock is a high-risk short heading into December earnings, with technical breakdown, consensus-dependent fundamentals, negative tangible book value, a narrowing competitive moat, and macro tail risks all pointing to asymmetric downside of 14-31% in a bear case scenario.
EV: -14% to -31% (Bear case: $250-310) · concedes: Consensus PE of 18.6x is technically below sector average; Q3 CY26 44.2% net margin demonstrates near-term execution capability; AI ASIC revenue run-rate ~$5-6B represents real business; Dividend coverage remains adequate
→ vs conservative: Anchored to short-term technical noise; reading management's disciplined deleveraging as fear when it signals balance sheet strength (net debt from 58B to 35B in 21 months) and a war chest building for next growth leg
→ vs conservative: Waiting for December earnings 'binary' catalyst means missing the entry; if AVGO beats the 19.39 forward EPS consensus, stock rips to 400+ in days and chasers buy 30 points higher
→ vs conservative: A PEG below 0.5 on a company with AVGO's growth rate has historically been an unambiguous buy signal; treating AR doubling as a red flag misreads working capital expansion as a bug when it's actually confirmation of real hyperscaler demand
→ vs neutral: Waiting for 367 reclaim or 334 flush for 'confirmation' is chasing; institutional buyers are accumulating at current levels and the technical setup is cleaner than perceived
→ vs neutral: Single-session breakdown below 50 and 200 SMAs on elevated volume is distribution at resistance, not a trend reversal; 200 SMA slope still rising and MACD histogram still positive at 2.98 contradict breakdown narrative
→ vs neutral: Sitting at neutral weight in a name with 30.6B FCF, 34% margins, PEG 0.37, and AI capex locked through 2026 is not risk management—it's opportunity cost
→ vs conservative: The same 'wait for confirmation' mentality caused this analyst to call AVGO 'too extended' at every pullback during the run from 289 to 495; the best entries in mega-cap tech always look broken short-term
AVGO technical posture has shifted from bullish continuation to neutral/slightly bearish consolidation following an Oct 8 distribution day. Price broke below both the 50 SMA (371.90) and 200 SMA (367.00) on volume of 26.74M shares with a -4.3% decline. The MACD histogram (2.98) remains positive but fading from a Oct 7 peak of 3.72, while RSI (49.44) has reset to neutral mid-band. Key support sits at 358.68 (VWMA) and 355.08 (BB middle), with critical lower support at 334.12 (lower Bollinger Band). Resistance levels to watch are 361.22 (10 EMA) and 367 (200 SMA) for potential reclaim confirmation. The balanced call is HOLD with downside vigilance—existing holders should tighten stops to ~350, while new long entries should wait for reclaim of 367 or a flush to 334-338 with reversal confirmation.
Market Cap
$1.72 T
Market Cap (exact)
$1,719.18 B
Trailing PE
45.99
Forward PE
18.57
PEG Ratio
0.37
Price/Book
17.25
EPS (TTM)
$7.83
Forward EPS
$19.39
Dividend Yield
0.69%
Beta
1.48
52-Week High
$495.00
52-Week Low
$289.96
50-Day Avg
$372.60
200-Day Avg
$368.09
Gross Margin (TTM)
~75.5%
Operating Margin
54.3%
EBITDA Margin
~58.7%
Profit Margin (Net)
42.9%
Return on Equity
44.2%
Return on Assets
15.4%
Total Assets
$188.15 B
Cash & Equivalents
$23.98 B
Net Debt
$35.44 B
Total Debt
$59.42 B
Stockholders' Equity
$99.69 B
Goodwill + Intangibles
$124.13 B
Tangible Book Value
($24.44 B)
Current Ratio
2.50
TTM Free Cash Flow
~$30.6 B
TTM FCF Margin
~34%
FY2025 Revenue
$63.89 B
FY2025 Net Income
$23.13 B
FY2025 Diluted EPS
$4.77
FY2025 Operating CF
$27.54 B
FY2025 FCF
$26.91 B
FY2025 Dividends Paid
$11.14 B
FY2025 Share Repurchases
$6.31 B
FY2025 Debt Repayment
$18.48 B
Q3 CY2026 Revenue
$29.59 B
Q3 CY2026 Operating Income
$16.06 B
Q3 CY2026 Net Income
$13.09 B
Q3 CY2026 Diluted EPS
$2.68
Q3 CY2026 FCF
$13.67 B
Q2 CY2026 FCF
$10.26 B
Q1 CY2026 FCF
$8.01 B
Q4 CY2025 FCF
$7.47 B
Q3 CY2025 FCF
$7.02 B
Net Debt Reduction Since 2024
~$23 B
Revenue YoY Growth Q3 CY26
~+44%
Strengths
Concerns
Constructively Bullish on AVGO — The combination of (a) AI-accelerator revenue inflection, (b) rapid deleveraging, (c) massive free cash flow (~$30.6B TTM), and (d) a forward PE of just 18.6x against a PEG of 0.37 strongly supports owning AVGO for growth-oriented portfolios. Principal risks are (i) deceleration of hyperscaler AI capex and (ii) valuation compression if the EPS ramp is delayed.
Macro: Fed is effectively in higher-for-longer mode with 96% probability of zero rate cuts in 2026; US recession odds are low at 6% (down 2pp week-over-week), supporting a soft-landing thesis; 10-year yields remain elevated with mortgage rates at nearly three-year highs, creating mild headwind for high-multiple tech; oil at $103 with geopolitical risk premium contained; gold at $4,131.80 (+0.44%) showing flight-to-quality bid without panic levels; Nasdaq and S&P holding weekly gains while small caps slip, indicating mega-cap tech leadership remains intact.